sotorasib,regorafenib,panitumumab
takeda,amgen,bayer
['sotorasib', 'crc,(-ccrcc),(-tbcrc049),(-mccrcc),(-mbcrc)', 'panitumumab', 'regorafenib']
another new kid on the kras g12c block : sotorasib, again with an egfri (panitumumab) in chemorefractory mcrc. phase 3 codebreak 300 (va regorafenib or tas102) ongoing 
GI oncologist, MD, PhD (FRA)